The healthcare and diagnostics sector continues to remain in focus among investors, especially in the SME IPO space. One of the most talked-about issues currently is the Modern Diagnostic IPO, with investors actively searching for Modern Diagnostic IPO GMP to gauge listing expectations.
In this detailed article, we cover Modern Diagnostic IPO GMP, price band, dates, lot size, investment details, and a clear IPO analysis, helping investors make an informed decision.
Modern Diagnostic IPO Overview
Modern Diagnostic IPO is a book-built issue with a total size of ₹36.89 crore. The issue is entirely a fresh issue, which means the company will utilize the entire IPO proceeds for business growth and operational requirements.
Key IPO Highlights
IPO Size: ₹36.89 crore
Fresh Issue: 0.41 crore shares
Issue Type: Book Built Issue
Listing Exchange: BSE SME
Modern Diagnostic IPO Dates
Here are the important dates related to the IPO that investors should track carefully:
IPO Open Date: December 31, 2025
IPO Close Date: January 2, 2026
Allotment Date: January 5, 2026 (Expected)
Listing Date: January 7, 2026 (Tentative)
Stock Exchange: BSE SME
Modern Diagnostic IPO Price Band & Lot Size
Pricing and lot size are critical factors, especially for SME IPO investors.
Price Band: ₹85 to ₹90 per share
Lot Size: 1,600 shares
Minimum Investment Details
Retail Investors
Minimum application: 2 lots (3,200 shares)
Investment amount: ₹2,88,000 (at upper price band)
HNI Investors
Minimum application: 3 lots (4,800 shares)
Investment amount: ₹4,32,000
Due to the higher minimum investment requirement, this IPO is more suitable for investors who are comfortable with SME IPO risk and capital exposure.
Modern Diagnostic IPO GMP (Grey Market Premium)
What is Modern Diagnostic IPO GMP?
Modern Diagnostic IPO GMP refers to the unofficial premium at which the IPO shares are traded in the grey market before listing. GMP gives an early indication of market sentiment and expected listing performance, though it is not guaranteed.
Why Modern Diagnostic IPO GMP Matters
Indicates demand among informal market participants
Reflects sentiment ahead of listing
Helps short-term investors assess listing gain potential
⚠️ Disclaimer: GMP is not an official price and can change frequently based on market conditions, subscription demand, and overall sentiment. It should be used only as a reference.
For live Modern Diagnostic IPO GMP updates, investors can regularly track Finowings’ IPO GMP section.
About Modern Diagnostic Limited
Modern Diagnostic Limited operates in the healthcare diagnostics segment, providing diagnostic testing and related medical services. With increasing awareness of preventive healthcare and rising demand for diagnostic services, the sector offers steady long-term growth potential.
The company plans to use IPO proceeds to:
Strengthen working capital
Support operational expansion
Improve service infrastructure
Being a 100% fresh issue, the funds directly contribute to the company’s future growth.
Key Strengths of Modern Diagnostic IPO
✅ Healthcare Sector Exposure – Defensive and growing industry
✅ Entirely Fresh Issue – No promoter exit
✅ SME Growth Opportunity
✅ Listing on BSE SME
Risks to Consider Before Investing
While the sector outlook is stable, investors should be mindful of the following risks:
⚠️ SME stock volatility post listing
⚠️ Lower liquidity compared to mainboard stocks
⚠️ Execution and expansion-related risks
A balanced view of Modern Diagnostic IPO GMP and company fundamentals is essential before investing.
Should You Apply for Modern Diagnostic IPO?
The IPO may be suitable if you:
Track Modern Diagnostic IPO GMP actively
Understand SME IPO risks
Are looking for listing gains or medium-term exposure
Long-term investors may consider observing the stock’s post-listing performance before taking a position.
Modern Diagnostic IPO – Quick Summary
Final Thoughts on Modern Diagnostic IPO GMP
Interest in Modern Diagnostic IPO GMP highlights strong curiosity among SME IPO investors. While GMP offers a snapshot of market sentiment, a smart investment decision should consider pricing, business fundamentals, risk appetite, and market conditions.
For live IPO GMP updates, upcoming IPO analysis, and SME IPO insights, stay connected with Finowings — your reliable destination for IPO information.
Post a Comment